HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
J E Herndon Selected Research
J E Herndon Research Topics
Disease
12
Neoplasms (Cancer)
02/2007 - 03/2000
9
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2004 - 04/2000
5
Glioma (Gliomas)
12/2009 - 03/2000
5
Leukemia
02/2007 - 04/2000
3
Lung Neoplasms (Lung Cancer)
10/2001 - 01/2001
2
Glioblastoma (Glioblastoma Multiforme)
10/2012 - 12/2009
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2007 - 05/2002
2
Malignant Mesothelioma
11/2001 - 02/2001
2
Brain Neoplasms (Brain Tumor)
10/2001 - 03/2000
2
Esophageal Neoplasms (Esophageal Cancer)
09/2001 - 03/2001
1
Hematologic Neoplasms (Hematological Malignancy)
10/2014
1
Hypoxia (Hypoxemia)
12/2009
1
Hypertension (High Blood Pressure)
12/2009
1
Adenocarcinoma of Lung
10/2006
1
Cardiotoxicity
11/2001
1
Neoplasm Metastasis (Metastasis)
10/2001
1
Disease Progression
10/2001
1
Carcinoma (Carcinomatosis)
09/2001
1
Prostatic Neoplasms (Prostate Cancer)
05/2001
1
Breast Neoplasms (Breast Cancer)
01/2001
1
Thrombocytopenia (Thrombopenia)
10/2000
1
Neutropenia
10/2000
1
Adenocarcinoma
03/2000
1
Retinoblastoma (Glioblastoma, Retinal)
03/2000
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2000
Drug/Important Bio-Agent (IBA)
3
Gemcitabine
FDA Link
02/2007 - 02/2001
3
Cisplatin (Platino)
FDA Link
Generic
05/2002 - 04/2000
3
Tumor Biomarkers (Tumor Markers)
IBA
09/2001 - 03/2001
2
Bevacizumab (Avastin)
FDA Link
10/2012 - 12/2009
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2009 - 10/2006
2
Etoposide (VP 16)
FDA Link
Generic
12/2009 - 05/2002
2
Irinotecan (Camptosar)
FDA Link
Generic
02/2007 - 03/2004
2
Docetaxel (Taxotere)
FDA Link
03/2004 - 05/2001
2
Angiogenesis Inducing Agents (Angiogenesis Factor)
IBA
10/2001 - 03/2000
2
Biomarkers (Surrogate Marker)
IBA
10/2001 - 01/2001
2
Proteins (Proteins, Gene)
FDA Link
08/2001 - 01/2001
2
Monoclonal Antibodies
IBA
11/2000 - 03/2000
1
Clostridium perfringens epsilon-toxin
IBA
10/2014
1
Carbonic Anhydrase IX
IBA
12/2009
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
12/2009
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
10/2006
1
Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
IBA
10/2006
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
10/2006
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
10/2006
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
11/2001
1
Dexrazoxane (Zinecard)
FDA Link
Generic
11/2001
1
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2001
1
Temozolomide (Temodar)
FDA Link
Generic
10/2001
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
10/2001
1
Plasminogen Activators (Plasminogen Activator)
IBA
10/2001
1
poliferprosan 20 drug combination carmustine (Gliadel)
FDA Link
10/2001
1
Plasminogen Inactivators
IBA
10/2001
1
Cadherins (E-Cadherin)
IBA
10/2001
1
Transforming Growth Factor beta (TGF-beta)
IBA
09/2001
1
Transforming Growth Factor alpha (TGF-alpha)
IBA
09/2001
1
Facilitative Glucose Transport Proteins (Glucose Transporter)
IBA
08/2001
1
Synaptophysin
IBA
08/2001
1
Estramustine
FDA Link
05/2001
1
Hydrocortisone (Cortisol)
FDA Link
Generic
05/2001
1
Hormones (Hormone)
IBA
05/2001
1
Fluorouracil (Carac)
FDA Link
Generic
03/2001
1
Platinum
IBA
03/2001
1
Paraffin
IBA
03/2001
1
Buffers
IBA
01/2001
1
Mucin-1 (CA 15-3 Antigen)
IBA
01/2001
1
Keratin-19 (Keratin 19)
IBA
01/2001
1
Iodine-131
IBA
11/2000
1
O(6)-benzylguanine
IBA
10/2000
1
Carmustine (FIVB)
FDA Link
10/2000
1
Fluorine
IBA
06/2000
1
Deoxyglucose (2 Deoxy D glucose)
IBA
06/2000
1
Ifosfamide
FDA Link
Generic
04/2000
1
Paclitaxel (Taxol)
FDA Link
Generic
04/2000
1
Vinorelbine (Navelbine)
FDA Link
Generic
04/2000
1
ErbB Receptors (EGF Receptor)
IBA
03/2000
1
Tenascin
IBA
03/2000
1
Factor VIII (Coagulation Factor VIII)
IBA
03/2000
1
sialosyl-Tn antigen
IBA
03/2000
Therapy/Procedure
8
Therapeutics
10/2012 - 03/2000
6
Drug Therapy (Chemotherapy)
12/2009 - 04/2000
2
Radiotherapy
10/2001 - 02/2001
1
Combined Modality Therapy
07/2004
1
Aftercare (After-Treatment)
10/2001
1
Cranial Irradiation
10/2001
1
Injections
03/2000